U.S. Consumer Services Stock News

Sands China, a subsidiary of Las Vegas Sands, took part as an Associate Partner at Art Central in Hong Kong. It is the first integrated tourism and leisure enterprise from Macao to join the international art fair in this role. The participation highlights a move to support cultural tourism and local artists beyond traditional gaming activities. Las Vegas Sands (NYSE:LVS), trading at $54.32, is drawing attention not only for its resort assets but also for how it uses culture to attract...

Kraft Heinz has cancelled its planned company break up after quietly ending merger talks with Unilever. New CEO Steve Cahillane is shifting focus to turning around the core business instead of pursuing large structural changes. The company plans to prioritize commercial growth, stabilizing volumes, and defending its brands in a competitive packaged food market. Kraft Heinz (NasdaqGS: KHC) is refocusing on its existing portfolio at a time when its share price sits at $22.27. The stock has...

Upstart Holdings (UPST) is back in focus after reporting strong loan origination growth, rising operating margins, and a fresh forward flow deal that supports up to US$1b of consumer loan purchases. See our latest analysis for Upstart Holdings. Despite the upbeat loan origination and funding news, the 30 day share price return of 10.33% and year to date share price return of 44.68% are characterized as weak. The 1 year total shareholder return of 46.76% contrasts with a positive 3 year total...

RH (RH) has wrapped up FY 2026 with fourth quarter revenue of US$842.6 million and basic EPS of US$1.53, capping a twelve month run where EPS on a trailing basis reached US$6.65 on revenue of about US$3.4 billion alongside a 72.4% year over year earnings recovery after several years of declines. Over the past eight quarters, revenue has moved from US$812.4 million in Q4 FY 2025 to US$842.6 million in Q4 FY 2026. Over the same period, quarterly EPS has ranged between US$0.75 and US$2.76 and...

MSA Safety: Recent Returns Put Multi Year Run In Context MSA Safety (MSA) has attracted attention after a mixed run in its shares, with a negative month and past 7 days, set against positive returns over the past year and multi year periods. See our latest analysis for MSA Safety. At a share price of $166.35, MSA Safety has recently seen a 16.06% 1 month share price decline after a weaker 7 day period. However, the 1 year total shareholder return of 12.54% and 3 year total shareholder return...

Celanese Corporation (NYSE:CE) has filed an omnibus shelf registration with regulators. The filing allows the company to offer common stock, preferred stock, and debt securities over time. This structure gives Celanese the ability to raise capital when market conditions and funding needs align. Celanese produces specialty materials and chemicals used across sectors such as automotive, construction, and consumer goods, so access to flexible funding can matter for large projects or potential...

Fresh geopolitical tension around President Trump’s threat to “completely obliterate” Iran’s energy infrastructure has pushed DNOW (DNOW) into focus, as investors weigh how potential supply disruptions could affect the distributor’s energy exposed business. See our latest analysis for DNOW. At a share price of $11.84, DNOW has recently seen weaker momentum, with a 90 day share price return of 10.64% and a 1 year total shareholder return of 31.60%. However, the 3 and 5 year total shareholder...

Wondering whether Uber Technologies at around US$71.71 is priced for opportunity or disappointment? This article walks through what the numbers are really saying about the stock’s value. The share price has seen a 1.9% decline over the last week, a 5.6% decline over the last month, and a 13.5% decline year to date, although the 3 year return sits at 130.4% and the 5 year return at 26.1%. These moves come as Uber continues to be a central name in ride hailing and delivery. Investors are...

In its latest quarter, ASGN reported revenue and adjusted EBITDA margins ahead of expectations but missed EPS forecasts, while also outlining integration of the Quinnox acquisition and a rebranding to Everforth to consolidate its seven brands. This combination of earnings mixed with margin outperformance and a pivot toward higher-value consulting and unified branding could meaningfully reshape ASGN’s business mix and competitive positioning over time. We’ll now examine how ASGN’s Quinnox...

Microsoft contract puts IREN’s AI pivot in focus IREN (NasdaqGS:IREN) is drawing fresh attention after securing a multi year US$9.7b contract with Microsoft for dedicated liquid cooled GPU clusters, a deal that supports recurring, higher margin AI infrastructure revenue. See our latest analysis for IREN. Despite some recent volatility, including a 7 day share price return decline of 17.72% and a year to date share price return decline of 20.16%, IREN’s 1 year total shareholder return of...

CoreWeave (CRWV) is drawing attention after recent trading, with the stock closing at $78.44 and showing mixed returns over the past week, month, and past 3 months as investors assess its cloud infrastructure business. See our latest analysis for CoreWeave. The 1 day share price return of 1.25% comes after a weaker 7 day share price return of 10.44%. The 1 year total shareholder return of 27.84% points to momentum that has built over a longer stretch despite recent volatility. If CoreWeave's...

Nebius Group (NasdaqGS:NBIS) is in focus after announcing a US$10b AI data center project in Lappeenranta, Finland, alongside large supply deals with Meta and Microsoft and a US$2b investment from Nvidia. See our latest analysis for Nebius Group. After a sharp rally recently, Nebius now trades at US$101.95, with a 30 day share price return of 12.02% and a year to date share price return of 13.34%. Its 1 year total shareholder return of 316.97% suggests very strong longer term momentum, while...

Incyte (NasdaqGS:INCY) released 54-week pivotal Phase 3 data from its STOP-HS program for povorcitinib in moderate to severe hidradenitis suppurativa (HS). The data show durable efficacy across multiple clinical response thresholds and improvements in patient quality of life at 54 weeks. Safety results were consistent over the long term, supporting the overall benefit risk profile of povorcitinib in HS. This is the first publication of long-term pivotal data for povorcitinib in HS ahead of...

ZIM Integrated Shipping Services recently saw sentiment soften as investors reacted to projections for a substantial year-over-year decline in its upcoming quarterly earnings and revenue. The lack of recent changes in consensus earnings estimates, alongside a Hold rating on the Zacks scale, underscores lingering uncertainty over ZIM’s near-term operating outlook. Against this backdrop of expected earnings and revenue pressure, we will examine how this cautionary earnings setup could reshape...

Recent commentary on Gold.com highlights how gold’s traditional role as a haven asset held firm despite a sharp price drop during the Middle East conflict, when liquidity needs temporarily pushed prices lower. The analysis points out that investors are now rebuilding gold exposure as concerns over global debt, currency debasement, and geopolitical risks persist, supporting renewed attention on the metal. We’ll now explore how persistent geopolitical and macroeconomic risks highlighted by...

Zai Lab announced in the past that it will collaborate with Amgen on a global Phase 1b trial combining Zai Lab’s DLL3-targeting ADC zocilurtatug pelitecan with Amgen’s IMDELLTRA for patients with extensive-stage small cell lung cancer. Separately, the FDA’s identification of dozens of Tavneos-linked liver injury cases, including severe events and deaths, raises fresh questions about Amgen’s safety and regulatory risk profile. Next, we’ll explore how the FDA’s Tavneos safety concerns could...

Oncolytics Biotech (NasdaqCM:ONCY) has completed its domestication from Canada to the United States. The company has relocated its headquarters to San Diego, with the move now effective. Oncolytics Biotech is now classified as a U.S. domestic issuer under the U.S. regulatory framework. The domestication is intended to support operational efficiencies and access to U.S. capital markets. For you as an investor, this shift touches on both regulation and capital access. Oncolytics Biotech is an...

Duke Energy (NYSE:DUK) has completed the sale of its Tennessee Piedmont Natural Gas business to Spire. The company plans to use the proceeds to support its regulated capital investment plan over the next five years. The move marks a shift in Duke Energy's portfolio toward grid and generation projects while aiming to manage customer costs. Duke Energy, trading at about $130.9 per share, is using this transaction to refine where its capital is focused. The company has delivered an 11.5%...

Coca-Cola plans a long term investment of $1 billion in South Africa to expand production and distribution capacity. The company is acquiring a majority stake in Coca-Cola Beverages Africa, covering South Africa and 14 additional African markets. The investment focuses on local hiring, operational expansion and deeper integration with regional partners over multiple years. Coca-Cola (NYSE: KO) is adding a major Africa focused chapter to its global story with this $1 billion commitment. The...

In recent weeks, Simply Good Foods has faced mounting concerns as Atkins brand sales declined in consecutive quarters and rising costs pressured margins, prompting scrutiny of its growth outlook. Beyond the immediate slowdown, the key question now is whether stronger brands like Quest and OWYN can offset Atkins’ weakness and reshape the company’s long-term earnings mix. We’ll now examine how Atkins’ sales slump and margin pressure affect Simply Good Foods’ existing investment narrative built...

If you are wondering whether Alibaba Group Holding's share price offers value right now, or if the market is pricing it fairly, this breakdown will help you connect the current price with what the business may be worth. The stock last closed at US$123.73, with returns of a 4.7% decline over 7 days, a 13.2% decline over 30 days, a 20.6% decline year to date and a 3.1% decline over the past year, set against a 32.1% gain over 3 years and a 42.2% decline over 5 years. Recent headlines around...

In March 2026, Jabil Inc. reported second-quarter results showing year-on-year growth in sales and net income, and issued third-quarter guidance calling for net revenue between US$8.10 billion and US$8.90 billion, U.S. GAAP operating income of US$398 million to US$458 million, and diluted EPS of US$2.36 to US$2.76. The company also lifted its full-year fiscal 2026 outlook to US$34.00 billion in revenue, underscoring how healthcare exposure and injector-pen manufacturing for weight-loss drugs...

Abbott Laboratories (ABT) just expanded its cancer diagnostics reach through a new integration with Flatiron Health’s OncoEMR, giving more than 1,600 community cancer centers streamlined access to its Precision Oncology testing portfolio. See our latest analysis for Abbott Laboratories. Despite the oncology integration and other recent moves such as the ESOP related shelf registration and investment in Whoop, Abbott’s 30 day share price return of 10.29% and year to date share price return of...

Planet Labs PBC (PL) is back in focus after filing a US$680.7m shelf registration tied to an ESOP related offering, alongside fresh quarterly results, wider net losses, and new revenue guidance. See our latest analysis for Planet Labs PBC. After the shelf filing and earnings release, Planet Labs PBC’s 1-day share price return of 9.87% contrasts with a 7-day share price return of negative 13.18%. A 90-day share price return of 55.73% sits alongside a 1-year total shareholder return of about...